Jun 2024
Conyers provided Cayman Islands legal advice to Sino Biopharmaceutical Limited in connection with the issue of an amount not exceeding RMB1.5 billion super short term commercial papers with maturity not exceeding 180 days on the National Association of Financial Market Institutional Investors.
Sino Biopharmaceutical Limited is a leading pharmaceutical conglomerate in China. It belongs to the Charoen Pokphand Group and is headquartered in Hong Kong and Beijing. Its business includes researching, developing, producing, and selling biopharmaceutical products. It was listed on the Hong Kong Stock Exchange in 2000 (Stock code: 1177).
Partner Christopher Bickley and Senior Associate Beverly Cheung of Conyers’ Hong Kong office advised on the matter working alongside King & Wood Mallesons (Beijing).